The Patent Finder

Apoptogen, Inc.

Also on record
Records under this name other than patents Apoptogen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Apoptogen, Inc.

PatentTitleStatus Expires Confidence
US 6,107,041Detection and modulation of IAPS for the diagnosis and treatment of proliferative disease
Formerly held
Term ended
Term ended Dec 16, 2018 · From the USPTO record
Term endedTerm ended Dec 16, 2018From the USPTO record
US 6,159,709XIAP IRES and uses thereof
Formerly held
Term ended
Term ended Jul 24, 2018 · From the USPTO record
Term endedTerm ended Jul 24, 2018From the USPTO record
US 6,133,437Modulation of IAPs for the treatment of proliferative diseases
Formerly held
Term ended
Term ended Feb 13, 2017 · From the USPTO record
Term endedTerm ended Feb 13, 2017From the USPTO record
US 6,656,704Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
Formerly held
Term ended
Term ended Aug 4, 2015 · From the USPTO record
Term endedTerm ended Aug 4, 2015From the USPTO record
US 6,689,562Mammalian IAP gene family, primers, probes and detection methods
Formerly held
Term ended
Term ended Aug 4, 2015 · From the USPTO record
Term endedTerm ended Aug 4, 2015From the USPTO record
US 6,541,457Mammalian IAP gene family, primers, probes and detection methods
Formerly held
Lapsed on the fee record
Ended Apr 1, 2015 · From the USPTO record
Lapsed on the fee recordEnded Apr 1, 2015From the USPTO record
US 6,495,339Method of identifying a compound that modulates XAF-mediated apoptosis
Formerly held
Lapsed on the fee record
Ended Dec 17, 2014 · From the USPTO record
Lapsed on the fee recordEnded Dec 17, 2014From the USPTO record
US 6,300,492Modulation of IAPs for the diagnosis and antisense treatment of proliferative disease
Formerly held
Lapsed on the fee record
Ended Oct 9, 2013 · From the USPTO record
Lapsed on the fee recordEnded Oct 9, 2013From the USPTO record
US 6,171,821XIAP IRES and uses thereof
Formerly held
Lapsed on the fee record
Ended Jan 9, 2013 · From the USPTO record
Lapsed on the fee recordEnded Jan 9, 2013From the USPTO record
US 6,107,088XAF genes and polypeptides: methods and reagents for modulating apoptosis
Formerly held
Lapsed on the fee record
Ended Aug 22, 2012 · From the USPTO record
Lapsed on the fee recordEnded Aug 22, 2012From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited